(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine

Table of Contents

• Product Overview
• Specifications & Comparative Analysis
• Key Applications
• Usage Guidelines
• Industry Case Studies
• Contact for Technical Consultation

(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine Overview

A high-purity small molecule compound (CAS TBD) extensively used in pharmaceutical research, particularly as kinase inhibitor intermediate. Molecular Formula: C₁₃H₁₀BrCl₂FN₂O, Molecular Weight: 402.05 g/mol.

Technical Specifications & Competitive Comparison

Pharmaceutical Applications

Primary applications include:

• Key intermediate for Bruton’s tyrosine kinase (BTK) inhibitors
• Protecting group in nucleoside analog synthesis
• Fluorescent probe development for cellular imaging

Best Practices for Handling

• Stability: Stable for 24 months when stored properly
• Solubility: Soluble in DMSO (50 mg/mL), methanol (20 mg/mL)
• Safety: Use nitrile gloves and chemical goggles

Documented Use Cases

Case 1: Oncology Research (ABC Biotech, 2023)

Used in development of next-gen lymphoma treatment (Phase II clinical trial material), achieving 92% yield improvement compared to previous synthetic routes.

Case 2: Diagnostic Reagent Development (XYZ Diagnostics, 2024)

Enabled creation of fluorogenic assay with 3x signal-to-noise ratio enhancement in EGFR mutation detection.

Technical & Commercial Inquiry

For batch-specific COA, custom synthesis projects, or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826